Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000070858-26-000395
Filing Date
2026-08-03
Accepted
2026-08-03 12:05:32
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5839
2 POWER OF ATTORNEY bac_poa_1.pdf EX-24 118612
  Complete submission text file 0000070858-26-000395.txt   171510
Mailing Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255
Business Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255 7043868486
BANK OF AMERICA CORP /DE/ (Filed by) CIK: 0000070858 (see all company filings)

EIN.: 560906609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89140 | Film No.: 261231342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)